| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/14/2011 | EP1885741B1 Lys-thr dipeptides and their use |
| 09/14/2011 | EP1631234B1 Compositions and methods for the treatment of cns injuries |
| 09/14/2011 | EP1610803B8 LH for use in maintaining one or more pregnancies by inducing accessory corpus luteum formation. |
| 09/14/2011 | EP1469869B1 Peptide useful in immunomodulation |
| 09/14/2011 | EP1445314B1 Novel glutamic acid receptor and utilization thereof |
| 09/14/2011 | EP1445264B1 Substance specific to pd-1 |
| 09/14/2011 | EP1377314B1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | EP1027440B2 Inhibitor protein of the wnt signal pathway |
| 09/14/2011 | CN1925865B Pharmaceutical compositions for prevention of overdose or abuse |
| 09/14/2011 | CN1903357B Liver hydrolytic peptide for injection and preparation method therefor |
| 09/14/2011 | CN1872879B Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage |
| 09/14/2011 | CN102186881A Glucagon-likepeptide1 derivatives and use thereof |
| 09/14/2011 | CN102186879A Modified erythropoietin (epo)polypeptides that exhibit increased protease resistance and pharmaceutical compositions thereof |
| 09/14/2011 | CN102186497A Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 09/14/2011 | CN102186496A Compositions and methods for treatment of kidney disorders |
| 09/14/2011 | CN102186495A Methods of enhancing opsonophagocytosis in response to a pathogen |
| 09/14/2011 | CN102186494A Whey and thymus function |
| 09/14/2011 | CN102186493A Nutritional composition to promote healthy development and growth |
| 09/14/2011 | CN102186492A Methods for determining the bioactivity of tgf-beta in a composition |
| 09/14/2011 | CN102186491A Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 09/14/2011 | CN102186490A Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration |
| 09/14/2011 | CN102186473A Compounds for the treatment of peripheral neuropathies |
| 09/14/2011 | CN102186360A Nutritional composition with anti-regurgitation properties |
| 09/14/2011 | CN102183665A Method and apparatus for monitoring anti-platelet agents |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102181450A Trichina Ts27 gene, encoding protein and application thereof |
| 09/14/2011 | CN102180973A Target multifunctional anti-embolism fusion protein as well as preparation method and application thereof |
| 09/14/2011 | CN102180971A Recombinant beta-amyloid peptide B cell epitope polypeptide chimeric antigen and preparation method and application thereof |
| 09/14/2011 | CN102180963A Glucagons like peptide-1 (GLP-1) analog and application thereof |
| 09/14/2011 | CN102180960A Induction method of massive individualized natural interferon |
| 09/14/2011 | CN102180951A Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof |
| 09/14/2011 | CN102180949A Polypeptide capable of specifically combining vessel endothelial growth factor and application thereof |
| 09/14/2011 | CN102180948A Short peptide having kidney protection function as well as preparation method and application thereof |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102180943A Production process of polypeptide medicament for assisting to reduce blood sugar |
| 09/14/2011 | CN102178977A Preparation with double functions of stopping bleeding and sustainedly releasing granulocyte colony stimulating factor and preparation method thereof |
| 09/14/2011 | CN102178960A Application of Tap73 gene to preparation of cancer stem cell chemosensitization medicine |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178939A Muramidase hydrolase external sterile cream for treating skin ulcer and preparation method thereof |
| 09/14/2011 | CN102178938A Marine lysozyme suppository and preparation method thereof |
| 09/14/2011 | CN102178937A Pharmaceutical composition for protecting liver and benefiting spleen and preparation method thereof |
| 09/14/2011 | CN102178936A Methods for preparing collagen oleostock and moistening eyedrops |
| 09/14/2011 | CN102178935A Preparation for resisting radiation, enhancing body immunity and preventing and treating tumors |
| 09/14/2011 | CN102178934A Preparation for increasing bone mineral density, preventing osteoarthrosis and enhancing immunity |
| 09/14/2011 | CN102178933A Preparation for preventing and treating osteoporosis and osteoarthrosis |
| 09/14/2011 | CN102178932A Preparation for relieving fatigue and enhancing immunity |
| 09/14/2011 | CN102178931A Recombinant human interleukin-12 preparation for injection and preparation method thereof |
| 09/14/2011 | CN102178930A Anti-acne composition containing epidermal growth factors and tea tree oil and preparation method thereof |
| 09/14/2011 | CN102178929A Application of ancylostoma caninum anticoagulant peptide (AcAP) and recombinant thereof in preparation of thrombus dissolving medicaments |
| 09/14/2011 | CN102178928A Application of cobra venom neurotoxin in drugs for treating ametropia |
| 09/14/2011 | CN102178927A Application of interferon-induced transmembrane protein 3 (IFITM 3) for preparing medicament against hepatitis B virus (HBV) infection |
| 09/14/2011 | CN102178926A Peptide for preventing or treating liver damage |
| 09/14/2011 | CN102178925A Novel eyesight protective agent lutein ophthalmic preparation |
| 09/14/2011 | CN102178686A Medicament and vaccine for polysaccharide-related disease and immunoassay product |
| 09/14/2011 | CN102178679A Application of pyrroloquinoline quinone to the bone marrow hemopoietic function after recovery of radiation |
| 09/14/2011 | CN102178662A Insulin carrier transdermal drug delivery preparation and preparation method thereof |
| 09/14/2011 | CN102178656A HM-3 polypeptide freeze-dried powder preparation and preparation method thereof |
| 09/14/2011 | CN102178654A Sustained-release microspheres and preparation method thereof |
| 09/14/2011 | CN102178648A Preparation method of metal ion-protein/macromolecule water phase-water phase suspension |
| 09/14/2011 | CN101817877B Active fragment of anti-opioid peptide |
| 09/14/2011 | CN101805396B Anti-opioid peptide antagonist peptide and use thereof |
| 09/14/2011 | CN101705218B Protease, preparation method of same, as well as application and pharmaceutical formulation thereof |
| 09/14/2011 | CN101618206B Composition for sobering up and protecting liver |
| 09/14/2011 | CN101612386B Application of active peptide of deer blood in preparing antihypertensive medicaments and health care products |
| 09/14/2011 | CN101578093B Method of drug delivery for bone anabolic protein |
| 09/14/2011 | CN101519435B Cyclic nonapeptide compound in Hsisha sponge and application thereof |
| 09/14/2011 | CN101514225B Self-polymerization polypeptide and preparation method and application thereof |
| 09/14/2011 | CN101513523B Medicine containing cell polypeptide growth factor and preparation method thereof |
| 09/14/2011 | CN101508993B Bullfrog lectin gene, encoded lectin and uses thereof |
| 09/14/2011 | CN101455844B PEG-erythrocyte-stimulating factor and preparation method and use thereof |
| 09/14/2011 | CN101428142B Process for producing recombinant human vascular endothelial inhibitor composition sustained-release microsphere |
| 09/14/2011 | CN101423554B Antivariant streptococcus polypeptide and use thereof and preparation method |
| 09/14/2011 | CN101284870B Polypeptides of anti-measles virus and human immunodeficiency virus and use |
| 09/14/2011 | CN101265292B Polypeptides substances, preparing method and use thereof |
| 09/14/2011 | CN101186637B Method for inhibiting influenza virus infection and medicament thereof |
| 09/14/2011 | CN101168050B Immunity regulating medicinal composition |
| 09/13/2011 | US8019557 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/13/2011 | US8017765 RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA) |
| 09/13/2011 | US8017760 Antisense modulation of PTP1B expression |
| 09/13/2011 | US8017753 Mycobacterial antigens expressed under low oxygen tension |
| 09/13/2011 | US8017748 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 09/13/2011 | US8017739 Conjugates of hydroxyalkyl starch and a protein |
| 09/13/2011 | US8017738 Hemopoietin receptor protein, NR10 |
| 09/13/2011 | US8017733 Covalent attachment of hydrophilic polymers, such as polyalkylene glycol polymers, also known as polyalkylene oxides, to biologically-active molecules |
| 09/13/2011 | US8017731 Hemopoietic receptor protein, NR10 |
| 09/13/2011 | US8017729 Nanographite structure/metal nanoparticle composite |
| 09/13/2011 | US8017728 Metal-binding compounds and uses therefor |
| 09/13/2011 | US8017727 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017725 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/13/2011 | US8017593 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 09/13/2011 | US8017591 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/13/2011 | US8017586 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 09/13/2011 | US8017585 CXCR4 antagonist and use thereof |
| 09/13/2011 | US8017584 Tumor associated antigens; fusion proteins; antibodies; keyhole limpet hemocyanin carrier enhances immunogenicity |
| 09/13/2011 | US8017583 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 09/13/2011 | US8017582 Immunostimulatory compositions and methods |
| 09/13/2011 | US8017581 MSH-agonist tripeptide conjugates |